CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...